The gut microbiota pattern predictive for development of Metabolic Syndrome and dietary modulation
Year: 2017
Type: dissertation
Abstract: Introduction: \nThe metabolic syndrome (MetS) is a condition characterized by a cluster of \nmetabolic disorders including abdominal obesity, glucose intolerance, dyslipidemia and \nhypertension. The MetS is related with the increasing prevalence of cardiovascular \ndisease (CVD) and type-2 diabetes mellitus (T2DM). The gut microbiota is a complex \necosystem consisted of trillions of microbes that have co-evolved with their host for \nhundreds of millions of years. During the last decade, a growing body of knowledge has \nsuggested that there is a compelling set of connections among diet, gut \nmicrobiota and human health. At present, it is known that microbial imbalance or \ndysbiosis of the gut microbiota is associated with metabolic disorders such as MetS, \nobesity, T2DM and CVD. In this context, the relationship between the composition of the \nintestinal microbiota and human health has led to the design of strategies to promote the \nprevalence of beneficial bacteria that improve health status. In this sense, studies are \nneeded to research the possibility the develop strategies to dilute microbial patterns \nassociated with metabolic diseases with the aim of predict and treat the course of the \ndisease. \nHypothesis: \nOur hypothesis is the existence of a gut microbiota pattern predicts the development \nof MetS. On the other hand, the null hypothesis is the absence of a specific pattern capable \nof predicting the development of MetS. \nObjectives: \nMain objective: \nTo determinate whether the composition of the intestinal microbiota and fasting \nand postprandial levels of Lipopolysaccharide (LPS) and Lipopolysaccharide Binding \nProtein (LBP) might predict the development of MetS, defined by the criteria established \nby National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP \nIII) for MetS, in a subpopulation of patients within the CORDIOPREV study with \ncoronary heart disease. Secondary objectives: \n1) To evaluate whether the chronic consumption of two healthy diets (Mediterranean diet \nand low-fat diet) may restore the gut microbiome dysbiosis in obese patients depending \non the degree of metabolic dysfunction. \n2) To analyze the differences in the composition of the intestinal microbiota and plasma \nlevels of LPS after consumption of two healthy diets (Mediterranean diet and low-fat diet) \nfor 3 years in PreDM patients who regressed from Normoglucemia (NGC) compared with \npatients who did not regressed during these time periods.
Institutions: Universidad de Córdoba, University of Córdoba
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: gut microbiota, metabolic syndrome, lipopolysaccharide, lipopolysaccharide-binding protein, dysbiosis, Mediterranean diet, low-fat diet, prediabetes, obesity, coronary artery disease, cardiovascular disease, type 2 diabetes, dietary modulation of microbiota, CORDIOPREV study, NCEP ATP III criteria
Open Access status: green
OpenAlex ID: W2775723081
